4.7 Article

Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p

Journal

JOURNAL OF NEUROLOGY
Volume 258, Issue 4, Pages 647-655

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-010-5815-x

Keywords

Frontotemporal dementia; Amyotrophic lateral sclerosis; Mendelian; Chromosome 9

Funding

  1. Motor Neuron Disease Assocaition (UK)
  2. Medical Research Council (UK) [G0700943]
  3. National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01 AG000951-06]
  4. Medical Research Council [G0801418B, G0700943] Funding Source: researchfish
  5. MRC [G0700943] Funding Source: UKRI

Ask authors/readers for more resources

Families with autosomal dominant frontotemporal dementia and amyotrophic lateral sclerosis (FTD/ALS) have previously been linked to a locus on chromosome 9p21. We describe the clinical phenotype and pathology of a large family with autosomal dominant FTD/ALS with nine affected members originating from Gwent in South Wales, UK. We also further refine the locus on chromosome 9p21 using a haplotype sharing approach and assess heterogeneity in 9p21 linked families. Within this family, affected individuals present with either FTD or ALS or both diseases simultaneously. In addition there was marked phenotypic variation including ataxia, Parkinsonism, psychosis and visuo-spatial cognitive deficits. The pathological features of the three cases described were consistent with type 2 FTD pathology, as previously reported in similar families. However, we also report distinctive cerebellar and glial pathology and a significant proportion of TDP-43 negative inclusions. No mutations in known genes for FTD or ALS were found. We identified a large 4.8-megabase haplotype on chromosome 9p21, which was shared by all affected family members. This haplotype overlaps and limits the previously reported FTD/ALS linkage region on chromosome 9p21. Sequencing of this region did not identify any evidence of a pathogenic exonic mutation. This suggests that the pathogenic change affects non-coding DNA and that the disease is caused by variation in gene or protein expression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available